Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women

被引：0
|
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 2009年 / 25卷 / 10期
关键词：
D O I：
10.2165/0042310-200925100-00007
中图分类号：
学科分类号：
摘要：
Aromatase inhibitors are a component of the standard treatment of hormone receptor-positive breast cancer in postmenopausal women. However, their use is associated with accelerated bone loss and an increased rate of fractures, in what is already an at-risk population group. It is important to screen for and prevent aromatase inhibitor-associated bone los. © 2009 Adis Data Information BV. All rights reserved.
引用
收藏
页码：23 / 26
页数：3
相关论文
共 50 条
  • [1] Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
    Gibson, L. J.
    Dawson, C. L.
    Lawrence, D. J.
    Bliss, J. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [2] Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
    Gibson, Lorna
    Lawrence, David
    Dawson, Claire
    Bliss, Judith
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [3] Bone Health in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors
    Zikan, Vit
    Zimovjanova, Martina
    Petruzelka, Lubos
    Pribylova, Jana
    Cabinakova, Michaela
    Raskova, Maria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [4] BONE LOSS IN WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS
    Zodelava, M.
    Tsikhiseli, G.
    Nijaradze, S.
    Tskhovrebashvili, N.
    Tatishvili, N.
    Tskhovrebashvili, M.
    Mamaladze, T.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S465 - S465
  • [5] Aromatase inhibitors for breast cancer in postmenopausal women
    Campos, SM
    ONCOLOGIST, 2004, 9 (02): : 126 - 136
  • [6] Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
    Cepa, M.
    Vaz, C.
    ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (04): : 323 - 330
  • [7] Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors
    Mincey, Betty A.
    Duh, Mei Sheng
    Thomas, Simu K.
    Moyneur, Erick
    Marynchencko, Maryna
    Boyce, Simone Peart
    Mallett, David
    Perez, Edith A.
    CLINICAL BREAST CANCER, 2006, 7 (02) : 127 - 132
  • [8] New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women
    de Jong, PC
    Blijham, GH
    NETHERLANDS JOURNAL OF MEDICINE, 1999, 55 (02): : 50 - 58
  • [9] Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer
    Emilio Bajetta
    Nicoletta Zilembo
    Ettore Bichisao
    Drugs & Aging, 1999, 15 : 271 - 283
  • [10] Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
    Hadji, P.
    Aapro, M. S.
    Body, J. J.
    Bundred, N. J.
    Brufsky, A.
    Coleman, R. E.
    Gnant, M.
    Guise, T.
    Lipton, A.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2546 - 2555
12345